A Phase 3, Randomized, Double-blind, Study of Belzutifan + Zanzalintinib Versus Belzutifan + Placebo in Participants With Advanced RCC Who Have Progressed on or After Both PD-1/L1 and VEGF-TKI Therapies in Sequence or in Combination (LITESPARK-034)
A Phase 3, Randomized, Double-blind, Study of Belzutifan + Zanzalintinib Versus Belzutifan + Placebo in Participants With Advanced RCC Who Have Progressed on or After Both PD-1/L1 and VEGF-TKI Therapies in Sequence or in Combination (LITESPARK-034)
Researchers are looking for new ways to treat advanced renal cell carcinoma (RCC).
A standard (usual) treatment for certain people with RCC is belzutifan (a study medicine), which is a targeted therapy. Targeted therapy is a treatment that works to control how specific types of cancer cells grow and spread. Researchers want to learn if adding another targeted therapy called zanzalintinib (another study medicine) can treat more people with advanced RCC than belzutifan alone.
The goal of this study is to learn if people who receive belzutifan and zanzalintinib live longer overall and without the cancer getting worse compared to people who receive belzutifan and placebo.
Inclusion Criteria:
The main inclusion criteria include but are not limited to the following:
Exclusion Criteria:
For exclusion criteria: The main exclusion criteria include but are not limited to the following:
Trialsites@msd.com1-888-577-8839
Marietta, Georgia 30060, United States
770-281-5124
CABA, Buenos Aires C1426AHB, Argentina
+541159507952
Ciudad de Buenos Aires, Buenos Aires 1181, Argentina
+541149590200
Mar del Plata, Buenos Aires B7600FZO, Argentina
RÃo Cuarto, Córdoba Province X5800ALB, Argentina
Rosario, Santa Fe Province S2000KZE, Argentina
CABA, C1426ANZ, Argentina
+541132218900
Macquarie University, New South Wales 2109, Australia
Curitiba, Paraná 80510-130, Brazil
Natal, Rio Grande do Norte 59062-000, Brazil
Ribeirão Preto, São Paulo 14026-610, Brazil
São José do Rio Preto, São Paulo 15090-000, Brazil
Le Mans, Pays de la Loire Region 72000, France
Saint Priest En Jarez, Pays de la Loire Region 42271, France
+33477917082
Munich, Bavaria 81675, Germany
Meldola, Emilia-Romagna 47014, Italy
Bologna, 40138, Italy
Roma, 00168, Italy
Amsterdam, North Holland 1066 CX, Netherlands
Siedlce, Masovian Voivodeship 08-110, Poland
Warsaw, Masovian Voivodeship 02-172, Poland
Gliwice, Silesian Voivodeship 44-102, Poland
L'Hospitalet de Llobregat, Barcelona 08908, Spain
Madrid, Madrid, Comunidad de 28007, Spain
Sıhhiye, Ankara 06230, Turkey (Türkiye)
+905439340493
Ankara, 06620, Turkey (Türkiye)
901-683-0055
+542234963224
+543584620273
+5493416955611
+543414484830
+543804436443X108
+54 2644229585
+552721250202
+55 41 99205-7755
+55 84 4009-5595
+55 16 3913-8181
+55 17 3201-5054
56958646664
+56985383586
56224205098
56229490970
56323320850
+420543132216
+420597374322
+420727854666
+420224966405
+420734236410
00 45 38689191
+4591167472
+33492031538
+33413427427
+33531155050
+33241354694
+33 243297908
00498941402522
+4936419329970
+4930450515288
+302132162543
+302105832549
+302104809667
+97247772688
+97297472555
97239378074
97235303030
+390543739100
0282244061
+390557949648
00390805593767
+390512142204
02 2390 3028
+39 0755784188
+39 0652666919
00390630155202
+31433877025
+3120 512 9111
+3170 210 2143
+48570783100
+48122958160
+48256403300
+48225725959
+48322788237
+82-2-2228-8138
+82-2-3010-5977
+82-2-3410-1767
+34955013068
+34932607744
+34914269393
+34934894350
+34928441738
+34913908339
+34961114229
+905372688986
+90 312 595 71 12
+9005378528123
0090 850 250 8 250
0161 918 2546